Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Ibex Earns European Certification for Complete Breast Pathology AI Suite
2+ hour, 3+ min ago (277+ words) Jul 24, 2026 | Anatomic Pathology, Breast, Digital Pathology | Ibex Medical Analytics has received In Vitro Diagnostic Medical Devices Regulation (IVDR) certification for its breast cancer diagnostic tools, according to a press release from the company. The certification covers Ibex Breast ER, PR,…...
Spotlight Medical Receives European Approval for AI Breast Cancer Test
1+ week, 3+ day ago (296+ words) Clinical Lab Products The software analyzes digitized tissue slides to help clinicians assess the risk of recurrence in patients with early-stage disease Spotlight Medical announced that its myStage Dx test, a prognostic test for ER+/HER2 early breast cancer, has received…...
Gene Test Identifies Breast Cancer Patients Who Can Safely Skip Chemotherapy
1+ mon, 2+ week ago (730+ words) Jun 9, 2026 | Breast | Results from the international OPTIMA trial indicate that a genomic test can identify many breast cancer patients who can safely avoid chemotherapy without increasing the risk of recurrence. The findings, presented at the 2026 American Society of Clinical Oncology…...
Artera Receives CE Marks for AI-Powered Prostate and Breast Cancer Tests
2+ mon, 2+ week ago (184+ words) May 5, 2026 | Breast, Cancer, Digital Pathology | Artera, a developer of multimodal AI-based prognostic and predictive cancer tests, announced it has received CE marking under the European Union In Vitro Diagnostic Regulation for the ArteraAI Prostate Biopsy Assay and the ArteraAI Breast…...
NIH awards $850,000 to support menstrual blood test for endometriosis
3+ mon, 3+ week ago (396+ words) Mar 31, 2026 | Womens Health | Investigators at Northwell Health’s Feinstein Institutes for Medical Research have received a total of $850,000 in prize funding from the National Institutes of Health’s Rapid Acceleration of Diagnostics Technology (RADx Tech) program to accelerate development of a noninvasive…...
Ultrasensitive ctDNA Test Outperforms Standard Metrics in Predicting Breast Cancer Outcomes After Neoadjuvant Therapy
3+ mon, 4+ week ago (261+ words) Mar 25, 2026 | Breast | A new prospective study has found that circulating tumor DNA (ctDNA) testing using NeXT Personal, developed by Personalis, Inc, outperforms traditional prognostic markers—including pathologic complete response (pCR) status, nodal status, and tumor grade—in predicting outcomes for…...